Crypto market analyst and on-chain data enthusiast. Breaking down the trends, narratives, and market cycles of Bitcoin, alts, and macroeconomics.
Has Also Written
Last updated:
January 24, 2024
Top Crypto Gainers Today on DEXTools
$NYRO, $TUCKER and $MELON are the top crypto gainers today on DEXTools as the broader crypto market attempts to rebound following recent sell pressure.
Bitcoin (BTC) was last up just over 1% in 24 hours and close to $40,000, as per CoinMarketCap.
Solana (SOL) and Internet Computer (ICP) were the biggest gainers, up 8% and 12% respectively.
But small-cap cryptocurrencies almost always take the mantle for the top crypto gainers each day.
That’s because their low level of liquidity means that relatively small buy pressure can easily result in fast exponential gains.
While blue-chip cryptocurrencies can offer good upside prospects, traders looking to make quick profits usually turn to low-cap markets.
Despite Wednesday’s rebound most major cryptos still look to be in a short-term downtrend.
Here are some of the top small-cap crypto gainers on Thursday as per DEXTools.
Top Crypto Gainers on DEXToolsNyro ($NYRO)A shitcoin called Nyro ($NYRO) has been pumping on Wednesday.
$NYRO was last up around 72,800% in the past 24 hours, as per DEXTools.
Still, its market cap is pretty tiny at only around $825,000, with under $70,000 in liquidity.
Potential investors should be very cautious that the token could be a scam.
It only has a DEXTscore of 25/99.
It also remains mostly unaudited, though Quick Intel shows it may be a mintable token.
Tucker ($TUCKER)A recently launched shitcoin called Tucker ($TUCKER), which is clearly based on the right wing US political commentator Tucker Carlson, has exploded and is one of the top crypto gainers on Wednesday.
$TUCKER is up 17,500% in the past 24 hours, as per DEXTools.
But the latest pump has seen it hit a market cap of only $915,000, and it has puny liquidity of just $26,000.
The token has just 300 holders and a low DEXTscore of 46/99.
But Investors should be cautious that it could be a scam, with the token’s smart contract still largely unaudited.
Catwifmelon ($MELON)A shitcoin called catwifmelon ($MELON) is attempting to ride off of recent hype in dogwifhat meme coins.
As per DEXTools, it was last up 43,600% on the day, making it one of the top crypto gainers today.
$MELON’s market cap was still a tiny $356,000, with liquidity of only around $40,000.
Investors should be very cautious that the token might be a scam, given its very low DEXTscore of 13/99.
The token’s smart contract also remains largely unaudited.
That means investors won’t know if malicious code has been inserted to rob them.
Crypto Alternatives to Consider
Low-cap coins can offer huge potential returns but also come with a lot of risk.
For those looking for a better probability of near-term gains, an alternative high-risk, high-reward investment strategy to consider is getting involved in crypto presales.
This is where investors buy the tokens of upstart crypto projects to help fund their development.
These tokens are nearly always sold cheaply, and there is a long history of presales delivering huge exponential gains to early investors.
Many of these projects have fantastic teams behind them and a great vision to deliver a revolutionary crypto application/platform.
If an investor can identify such projects, the risk/reward of their presale investment is very good.
The team at Cryptonews spends a lot of time combing through presale projects to help investors out.
Here is a list of 15 of what the project deems as the best crypto presales of 2023.
Enzyme enables the creation and scaling of your chosen investment strategies, from discretionary and robo to ETFs and market making. The second-generation smart contract-based platform is extensively tested and audited before any mainnet deployment.
Formerly known as Melon Protocol, Enzyme Finance is a protocol built on Ethereum (ETH) that allows users to create, manage, and invest in custom crypto asset management tools.
Enzyme aims to decentralize traditional asset management, historically the domain of professional financial advisors and firms. The idea is to reduce entry barriers into asset management with the MLN cryptocurrency, thereby providing access to more global consumers.
For example, managed funds typically require a minimum investment amount and management fees, which can make these wealth tools inaccessible to the average consumer. Today, the capabilities to create asset management funds, requiring significant capital and legal counsel, are also out of reach. Moreover, filing documents for a fund can take years.
At this point, Enzyme aims to create an alternative system. Using the project’s web portal, users can invest in funds and portfolios initiated by other users, and other users can invest in their creations. The Enzyme Finance protocol uses the MLN cryptocurrency to execute various transactions on the platform.
Enzyme Finance, formerly Melon, was built by Melonport, a private company founded in 2016 by former Goldman Sachs Vice President Mona El Isa and mathematician Rito Trinkler.
Between 2017 and 2018, 1,250,000 MLN cryptocurrencies were created and distributed by the Switzerland-based company. Melonport raised $2.9 million in an ICO in 2017. In 2019, after delivering the first version of the Enzyme Finance protocol, Melonport was dissolved and its management was transferred to the Melon Council, a decentralized autonomous organization (DAO).
How to Buy Enzyme Coin?MLN Coin can be quickly and securely purchased through Binance, the world’s largest cryptocurrency trading platform by trading volume, via Binance.
To buy MLN Coin, one must first register with Binance and then send fiat money. After sending fiat currency, such as dollars, one can buy MLN Coin in trading pairs with Bitcoin (BTC), Tether (USDT), Binance Coin (BNB), and BUSD.
Additionally, on Binance, users can place buy orders not only at the market price but also at a lower value. For this, use the Limit tab and enter the amount and price you want to buy.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
Binance has issued a warning that has fueled discussions in the crypto market. For context, the leading cryptocurrency exchange announced plans to extend its Monitoring Tag to 11 tokens, putting them at risk of future delisting.
Meanwhile, tokens affected include Balancer (BAL), and Cortex (CTXC), among others, while Enzyme (MLN) and Horizon (ZEN) will be removed from the risk list. Several market watchers view this development as a signal for potential price volatility for the affected tokens.
Binance Adds Monitoring Tag To 11 Tokens Binance’s recent announcement about its Monitoring Tag has sent ripples through the crypto market. As of July 1, the exchange will add several tokens, including Balancer (BAL), Cortex (CTXC), and Convex Finance (CVX), to its Monitoring Tag list.
Meanwhile, as per the announcement, tokens with this tag are considered high-risk and are closely monitored for volatility and compliance with Binance’s listing criteria. The tokens newly added to the Monitoring Tag list are:
Balancer (BAL), Cortex (CTXC), PowerPool (CVP), Convex Finance (CVX), Dock (DOCK), Kava Lend (HARD), IRISnet (IRIS), MovieBloc (MBL), Polkastarter (POLS), Status (SNT), Sun (SUN).
In contrast, Enzyme (MLN) and Horizon (ZEN) will be removed from the Monitoring Tag list. This shift indicates a reassessment of the risks and stability associated with these tokens. However, Binance’s decision to tag these 11 tokens highlights their increased volatility and potential for not meeting the platform’s listing criteria in the future.
Meanwhile, according to Binance, the Monitoring Tag serves as a warning that the listed tokens are under scrutiny and may face delisting if they fail to meet specific standards. These standards include the project’s commitment, development activity, trading volume, network stability, public communication, and ethical conduct.
Binance emphasizes that the Monitoring Tag aims to maintain a healthy and sustainable cryptocurrency ecosystem.
Also Read: 900M SHIB Burn Sparks Optimism Over $0.00003 Price Target Ahead
Price Drop Ahead? The introduction of the Monitoring Tag for these tokens has significant implications for investors. Historically, announcements of this nature from major crypto exchanges like Binance tend to impact market sentiment and token performance. Positive announcements usually boost market confidence, while warnings and potential delistings can weigh on investors’ sentiment.
Meanwhile, the affected tokens could experience increased price volatility and reduced trading volume as investors respond to the perceived risk. Tokens under the Monitoring Tag are also subject to additional trading restrictions on Binance.
In addition, users must complete a quiz every 90 days to trade these tokens, ensuring they understand the associated risks. This additional layer of scrutiny aims to protect users and promote informed trading decisions.
The announcement underscores the importance of due diligence in the rapidly evolving crypto market. Investors must stay informed about the status and compliance of their holdings, particularly in light of such warnings from leading exchanges. In other words, Binance’s criteria for the Monitoring Tag emphasize the importance of project transparency, network stability, and ethical conduct.
Also Read: Elon Musk Announces JARVIS-Inspired xAI Grok 2 AI Chatbot Release Date
Enzyme Coin (MLN) is the native cryptocurrency of Enzyme, a protocol aimed at simplifying on-chain asset management for the DeFi ecosystem.
What is Enzyme (MLN)?Enzyme (MLN) is an Ethereum-based decentralized asset management infrastructure. Using Enzyme Smart Vaults, individuals and communities can create, scale, and monetize investment strategies utilizing the latest innovations in decentralized finance.
Enzyme Finance was formerly known as the Melon protocol. It now has a new symbol and name, though the MLN token and contract address remain the same. MLN is used to pay for various functions throughout the vault creation process and investment cycle.
Enzyme allows depositors to interact with smart vaults in a non-custodial setup that requires minimal trust between parties. Vault managers can be restricted to or prohibited from certain actions. Additionally, using the Enzyme infrastructure, live data for both performance and fees that can be proven with on-chain data are available.
Policies such as fees or transactions related to investments can be quickly configured and enforced at the vault level on the platform. Vaults can be delegated to third-party addresses for trading and other functions. To manage a vault, one can go to the “Vault Manager” section in the Enzyme application and create a new vault. It is recommended to use the user documentation as a guide for setup.
Where to Buy MLN Coin?MLN Coin can be securely bought and sold on Binance, the world’s largest cryptocurrency exchange by trading volume. Enzyme Coin is traded on the Binance platform in pairs such as MLN/BTC, MLN/BNB, MLN/BUSD, and MLN/USDT.
To purchase MLN, one must first register on the Binance exchange. After completing the registration, cryptocurrency or fiat currency should be transferred to the Binance wallet. Once the transfer is complete, BarnBridge Coin can be purchased from any of the four pairs mentioned above. To buy from the MLN/USDT trading pair, first, go to the interface of this pair. In the limit tab of the MLN/USDT interface, enter the desired amount to purchase. After specifying the amount, the purchase is completed with the Buy MLN order.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
Enzyme Finance, an Ethereum-based decentralized platform for asset management on-chain, has announced its new partnership with Compound DAO, an Ethereum-based DeFi protocol that permits crypto borrowing and lending. The partnership aims to optimize the management of treasury via unique on-chain options. The platform shared the details of this initiative in a recent X post.
Onchain options are becoming a way to make treasuries work harder. Here’s an example 👇@compoundfinance DAO recently demonstrated a sophisticated approach by integrating covered calls into their treasury strategy using Enzyme.Myso, targeting a ~15% APY.
The objective is… pic.twitter.com/ZhDJDQoQ1t
— Enzyme (@enzymefinance) July 13, 2025 Enzyme Finance and Compound Collaborate for Optimized Treasury Management The collaboration between Enzyme Finance and Compound DAO focuses on treasury management with robust optimization. This development underscores a noteworthy step in the evolution of decentralized autonomous organizations (DAOs) to enhance capital management. In this respect, the partnership integrates covered calls, which is an options strategy to generate yield while also retaining asset exposure. With this, Compound DAO targets a 15% annual percentage yield (APY).
Keeping this in view, the development is devoted to enhancing the idle assets’ productivity while maintaining a controlled and clear risk profile. At the core of this collaboration is Enzyme.Myso, which is a DeFi-native platform to enable execution and creation of diverse strategies concerning on-chain options. With local support for completely auditable flows as well as a framework for institutional-level DAOs and apps, Enzyme.Myso delivers the security and transparency that treasury operations require.
Driving Shift in DeFi Sector with Responsible Deployment of Idle Funds to Offer Sustainable Growth According to Enzyme Finance, Compound DAO’s integration of covered calls highlights a wider trend toward data-led and professionalized treasury management among decentralized organizations. Conventionally, DAOs have frequently faced capital inefficiency, often holding huge balances in governance tokens or stablecoins without any yield generation.
However, now, this partnership denotes a strategic shift in the case of responsible deployment of such funds for sustainable expansion. Overall, the joint effort plays the role of a blueprint for the rest of the institutional players and DAOs attempting to leverage DeFi options sector.
AUTHOR
Umair Younas is a cryptocurrency-related content writer linked with this work since 2019. Here, at Blockchainreporter, he serves as a news and article writer. He is a crypto, blockchain, NFTs, DeFi, and FinTech enthusiast. He has strong command over writing authentic reviews about brokers and exchanges and he has collaborated with our education team to write educational content as well. He has a dream to raise awareness among people about digital currencies. His works are well-researched and brimmed with information hence they provide fresh insights. Stay tuned to his posts if you want to stay up-to-date with the crypto-verse.
Nerite choses Onyx as their turnkey tech stack to seamlessly expand the utility of tBTC
We are proud to support Nerite, a decentralized borrowing protocol enabling users to deposit ETH, liquid staking tokens, and ARB as collateral to mint USND, its capital-efficient stablecoin. Built as a friendly fork of Liquity v2, Nerite gives borrowers flexibility and control by allowing them to set their own interest rates and manage collateral efficiently.
Capitalizing on a Flexible, Chain-Agnostic Architecture
The strategy borrows USND against tBTC collateral and deploys it within Nerite and other DeFi protocols integrated with USND, benefiting from Onyx’s flexible infrastructure that removes protocol and network limitations. It adjusts to market conditions to manage risk and preserve efficiency, with yield periodically rebalanced into tBTC. The fund is curated and managed by AGF through a Safe multisig wallet, processes deposits and redemptions daily, and leverages protocols such as Nerite, Aave, and Yearn, with a mandate centered on tBTC and USND.
By bringing this strategy on-chain through Enzyme Onyx, Nerite enables tBTC holders to access a growing borrowing and yield ecosystem on Arbitrum without compromising security, transparency, or operational flexibility.
Interested in building your own tokenized strategies or products on Onyx? Connect with our team and explore what Enzyme can power for you: https://enzyme.finance/contact-us
Enzyme is proud to be integrating the Chainlink Runtime Environment (CRE), a new orchestration layer designed for institutional-grade smart contract operations.
Enzyme is proud to be integrating the Chainlink Runtime Environment (CRE), a new orchestration layer designed for institutional-grade smart contract operations. This will enhance the capabilities of Enzyme Onyx by enabling seamless administration of complex tokenized financial products across both traditional and decentralized ecosystems.
As demand grows for funds and financial instruments deployed on-chain with exposure to real-world assets, multi-chain portfolios, and hybrid strategies, the need for accurate and compliant reporting becomes essential. The integration of CRE will support Onyx users by streamlining valuation and reporting processes across networks, systems, and data sources in a unified and scalable manner.
Chainlink Runtime Environment
CRE is an all-in-one orchestration layer that enables institutional-grade smart contracts to interoperate effortlessly with blockchains, APIs, and traditional financial systems. It brings data, compliance, privacy, and operational integrity to environments where multiple systems need to communicate reliably. This unlocks a future where on-chain finance is not siloed from the broader financial ecosystem but connected to it in a seamless and verifiable way.
What CRE Unlocks for Enzyme Onyx
Onyx empowers asset managers and issuers to create, launch, and scale tokenized investment products capable of executing sophisticated strategies across any asset class or market environment. As these strategies increasingly span multiple blockchains (L1s, L2s) and offchain venues, maintaining accurate, compliant, and timely reporting becomes a major operational challenge.
With the integration of CRE, Onyx removes this complexity. Managers and issuers no longer need to rely on manual data collection, error-prone spreadsheets, or costly third-party attestations. NAV and performance data are automatically sourced and verified from onchain, CeFi, and traditional systems—providing real-time transparency and credibility that meet institutional expectations.
Powered by Enzyme’s modular architecture, Onyx cleanly separates administrative functions (NAV reporting, compliance, vehicle setup) from execution layers (strategy management, protocol interactions). This design ensures that all data pipelines remain secure, verifiable, and automated end-to-end.
By connecting directly to APIs, custodians, CeFi venues, and traditional brokerage systems, Chainlink CRE delivers the interoperability and reliability required for institutional-grade accounting and reporting. The result is a more efficient and scalable platform—one that enhances investor confidence, simplifies fund operations, and enables managers and issuers to grow faster with less operational friction.
This integration reinforces Enzyme’s commitment to delivering a complete infrastructure for tokenized finance. By combining Onyx’s flexibility with Chainlink’s data and orchestration capabilities, we continue to expand the operational foundation required for regulated, scalable, and efficient financial products on-chain.Interested in building your own tokenized strategies or products on Onyx? Connect with our team and explore what Enzyme can power for you: https://enzyme.finance/contact-us
Passif is a digital asset investment manager, focused on delivering stable, risk-adjusted performance independent of market direction. Their flagship product, the Passif Alpha Fund, is a tokenized hedge fund engineered to preserve capital while enabling daily liquidity and real-time investor visibility into strategy activity.
The Challenge
Running modular, market-neutral strategies across multiple DeFi venues comes with significant operational demands. Strategy execution, risk controls, fee enforcement, and investor reporting must remain accurate and transparent at all times. For an investment manager focused on institutional discipline, building and maintaining the backend systems required to support this environment can divert resources from strategy, slow innovation, and restrict scale.
Passif sought an infrastructure that could uphold rigorous governance and transparency while simplifying fund administration and enabling seamless growth.
The Solution : Onyx for seamless administration
Onyx gives Passif the foundation to design, launch, and operate a tokenized hedge fund entirely on-chain. Granular accounting, fee frameworks, and subscription reporting capabilities are built directly into the infrastructure, reducing dependence on custom systems and materially simplifying operational overhead. Passif gains the ability to scale a sophisticated, multi-strategy portfolio while preserving investor safeguards and clear visibility into fund activity.
“We built Passif to deliver stable, market-independent returns, something traditional finance has stopped delivering. Onyx lets us structure and run our entire fund stack without ever touching custom infrastructure. It is fast, clean, modular, and investor-friendly by design. We needed a platform that gives our investors clear transparency and seamless scalability.”
— Eriz Zarate, Founder, Passif
Executing a Hedge Fund strategy with Ledger Wallets
The Passif Alpha Fund is a delta-neutral hedge fund designed for investors seeking consistent yield alongside strict capital preservation. Powered by Passif’s proprietary NeutralLoop™ framework, the fund reallocates stable-value assets across multiple hedged DeFi strategies, targeting 3–4× capital efficiency while eliminating directional market exposure.
Through Enzyme’s flexible architecture, capital can be deployed across a wide range of integrated venues including Pendle, Morpho Blue, Aave V3, Curve, Convex, EigenLayer, Swaap, Gearbox and others. Onyx removes the infrastructure constraints that typically limit multi-protocol execution, allowing Passif to operate its strategy with full modularity.
Execution of the underlying strategy is carried out using Ledger hardware wallets, bringing hardware-level security to day-to-day strategy management. Investors still benefit from T+0 liquidity and real-time visibility into activity, while Onyx maintains the operational structure needed for an institutional-grade experience.
Results and Benefits
• Accelerated time-to-market
• Adaptability with Passif’s homemade strategy automation framework NeutralLoop™
• Governance and transparency aligned with institutional expectations
• Scalable product architecture that supports future strategy expansion
• Real-time investor engagement and T+0 liquidity
• No backend engineering required
Call to Action
Are you building the next generation of tokenized financial products? Connect with our team to learn how Onyx can support your strategy. https://enzyme.finance/contact-us
Enzyme is pleased to announce a strategic partnership with CV5 Capital, a leading regulated platform for launching institutional-grade hedge funds and digital asset funds in the Cayman Islands.
Through this collaboration, CV5 Capital is adopting Enzyme Onyx as the foundational technology stack powering the issuance and administration of its tokenized fund offerings.By integrating Onyx across the CV5 Digital SPC umbrella, fund managers can now structure, launch, and operate next-generation investment vehicles, with full regulatory oversight, across a broad range of asset classes, including cryptocurrencies, securities, commodities, and real-world assets such as U.S. Treasuries.
Reinventing regulated fund infrastructureThis partnership combines CV5’s CIMA-regulated Cayman fund architecture with Enzyme’s decentralized, programmable asset management infrastructure, giving managers the ability to issue, structure and administer tokenized hedge funds capable of delivering strategies across any asset class.
“We’re thrilled to collaborate with CV5 Capital in setting a new standard for institutional-grade tokenized funds,” said Mona El Isa, Founder of Enzyme. “Together, we’re making asset management more transparent, efficient, and composable, while preserving the compliance and investor protections institutions rely on.”
David Lloyd, Founder and CEO of CV5 Capital, added: “By integrating Enzyme’s on-chain infrastructure into our regulated framework, we can deliver transparent and compliant fund structures that institutional investors can trust. It’s a significant step toward uniting DeFi and regulated finance.”
What This Means for Fund Managers and InvestorsFunds launched under the CV5 Digital SPC umbrella will now benefit from Enzyme Onyx complete Administration tools for granular administration controls across Accounting, Subscription and Fee management.
The partnership will initially support a series of tokenized fund strategies, including market-neutral digital asset products, Bitcoin treasury vehicles, and tokenized credit opportunities.
Looking to launch a Cayman-regulated hedge fund? Contact us now!
Setting a New Benchmark for Tokenized Fund InfrastructureBy combining Enzyme’s on-chain operating system with CV5 Capital’s regulated fund platform, we are building one of the most complete environments available for managers seeking to deploy tokenized hedge funds and digital asset portfolios, with the reliability, governance, and transparency institutions expect.
Enzyme, the global infrastructure for tokenized finance, and Particula, the prime rating provider for digital assets, today announced a strategic product partnership aimed at empowering asset managers and product issuers to streamline the launch of risk-rated tokenized investment products and facilitate institutional distribution across the onchain economy.
At the core of the collaboration is the integration of Enzyme’s Onyx solution with Particula’s RWA risk‑intelligence framework. Enzyme Onyx provides a technology stack for issuing and administering tokenized funds and instruments, including ETPs and structured notes. Particula applies its rules-based methodology to deliver independent risk ratings and ongoing monitoring across structural design, counterparty risk, underlying asset quality, and other key risk factors.Together, the integration creates a unified environment enabling issuers to design, launch, and scale tokenized products with embedded risk assessment capabilities from inception.
A Product Partnership Designed for the Next Wave of RWA Issuers
This partnership offers RWA issuers a streamlined way to design, launch, manage, and distribute tokenized financial products onchain. Key capabilities include:
Build products aligned with recognized industry best practices.Embed transparent, real time risk ratings to strengthen investor trust.Leverage modular risk, compliance, and lifecycle tooling natively integrated into the product’s smart contracts.Tap into a growing distribution network of onchain allocators and marketplaces.Position your offerings competitively as true institutional-grade investment instruments.“This partnership meaningfully reduces the friction allocators face when evaluating and deploying capital into structured onchain products. With Particula’s ratings integrated, allocators can finally access risk-assessed RWA opportunities with clarity and confidence”, said Luca Mossini, Enzyme.
Independent Risk Assessment as a Market StandardAs the RWA market matures, third-party risk differentiation is becoming increasingly important for capital allocation decisions. Particula's framework generates granular, machine-readable risk scores across credit, commodity-backed, receivable-based, and structured RWA products, which can be integrated into Enzyme Onyx vaults.
This allows issuers to:
Demonstrate greater transparency and credibility with investors and regulators.Attract capital markets participants who require institutional-grade risk frameworksCompete more effectively in a market where risk premiums and ratings increasingly guide capital flows“Enzyme makes it possible for issuers to create tokenized products seamlessly while embedding risk ratings at the very beginning of the design process. This raises the standard for RWA structuring onchain”, said Nadine Wilke, Particula.
*Disclaimer
Particula maintains full independence in its assessment processes. This partnership pertains exclusively to technical infrastructure integration and does not influence Particula's analytical independence, methodologies, assessment criteria, or risk rating determinations. All instruments utilizing Enzyme infrastructure are subject to Particula's standard rules-based assessment criteria and methodologies, applied consistently without modification, preferential treatment, or commercial consideration. Particula maintains internal policies to identify, manage, and disclose actual and potential conflicts of interest in accordance with industry best practices.
About EnzymeEnzyme is a global leader in Tokenized Finance Infrastructure, providing industry leaders with advanced solutions to issue, manage and scale tokenized products and strategies. Since 2017, Enzyme has evolved from a pioneer in on-chain asset management to a trusted and global infrastructure partner for businesses navigating the tokenized economy. Our solutions include Enzyme Onyx, a core technology stack for issuing and administering tokenized funds and financial instruments, and Enzyme Myso, a leading protocol for creating and managing on-chain options.
About ParticulaParticula is the prime rating provider for digital assets, transforming on- and off-chain data into actionable insights. The company delivers next-generation risk ratings and comprehensive analyses, across technical, economic, governance, and compliance dimensions – providing the clarity and confidence needed to navigate the complexities of digital finance.
Improving transparency, NAV accuracy, and lifecycle reporting for on-chain vaults.
Enzyme, a leading onchain asset management infrastructure provider, and 1Token, a globally recognized digital asset accounting and reporting platform, today announced a strategic product partnership aimed at improving transparency, NAV accuracy, and lifecycle reporting for onchain vaults.
Through this integration, vault managers will be able to generate verified NAV calculations, reconcile holdings across both CeFi and DeFi, and surface real-time transparency reports directly within the Enzyme smart contract layer. This gives investors a clearer, more reliable view of vault activity while reducing operational friction for product managers.
Enhancing transparency and reporting for vault managers and investors
The partnership combines Enzyme’s latest stack for tokenized funds and instruments issuance with 1Token’s institutional-grade accounting stack, enabling managers to:
Produce accurate NAV, PnL and key risk metricsTrack holdings across CeFi and DeFi with unified reconciliationGenerate reconciled trade reports for further financial reporting Offer investors a reliable, verifiable view of assets, flows, and historical activityThis integration removes a longstanding pain point in on-chain asset management: the difficulty of delivering transparent, consistent, and auditable reporting across fragmented ecosystems and data sources.
“With 1Token’s accounting and CeFi and DeFi data capabilities integrated into Enzyme, we are removing one of the biggest frictions for allocators: gaining trustworthy, verifiable visibility into how capital is deployed across both onchain and centralized venues. This level of transparency is essential for unlocking the next wave of institutional flows into structured onchain products, and it helps avoid the blackboxes that leave investors in the dark during periods of market stress” - said Luca Mossini, Enzyme.
A unified transparency stack across DeFi and CeFi
This partnership builds on Enzyme’s growing data ecosystem, extending it with critical CeFi coverage. 1Token fills a long-standing gap for managers operating hybrid strategies by unifying CeFi and DeFi data into a single, auditable accounting framework, including full NAV, PnL, and reconciliation tooling.
Chainlink further enhances this stack by enabling issuers to define custom price oracles and bespoke valuation logic directly within on-chain vaults and ERC-20 shares.
What this means for product issuers in DeFi and RWA using Enzyme?
Unified tracking of both on-chain and CeFi positionsThe ability to display complete portfolio views, including exchange balances, wallets, LP positions, and cross-chain exposuresSupport for creating custom price oracles, powered by Chainlink, enabling issuers to feed vaults with bespoke pricing modelsMore transparent, accurate, and investor-ready reporting, including verified NAV and audit-grade lifecycle accountingA simplified workflow for building products that attract institutional capital, thanks to reduced friction in transparency and verification“Enzyme’s architecture allows managers to build sophisticated products while embedding accurate accounting and CeFi tracking directly into the design phase. We are excited to bring 1Token’s institutional reporting capabilities to Enzyme vaults and help issuers deliver world-class transparency to their investors,” - said Gloria Yao, 1Token.
About EnzymeEnzyme is a global leader in Tokenized Finance Infrastructure, providing industry leaders with advanced solutions to issue, manage and scale tokenized products and strategies. Since 2017, Enzyme has evolved from a pioneer in on-chain asset management to a trusted and global infrastructure partner for businesses navigating the tokenized economy. Our solutions include Enzyme Onyx, a core technology stack for issuing and administering tokenized funds and financial instruments, and Enzyme Myso, a leading protocol for creating and managing on-chain options.
About 1Token1Token is a leading institutional crypto asset management platform serving 80+ clients managing over $20B in AUM across the US, EU, and APAC. 1Token's SOC 2 certified platform provides integrated PMS, RMS, and accounting & reporting software across 80+ CeFi exchanges and 130+ DeFi chains. The platform delivers real-time dashboards, automated NAV calculations, reconciled transaction history, and audit-grade analysis reports for institutional compliance.
Enzyme is pleased to announce that two of its flagship protocols — Enzyme Onyx and Enzyme Myso — will be ported to the Canton Network, making them natively available on both EVM-compatible chains and Canton. Expected to launch in early Q3, this marks a significant milestone in Enzyme's commitment to building financial infrastructure that is not only technically robust, but positioned at the forefront of the emerging institutional blockchain landscape.
Enzyme Onyx and Enzyme Myso: A Brief OverviewEnzyme Onyx is the complete technical stack for issuing, structuring, and administering tokenized funds and financial instruments. Built for the innovators of modern markets, Onyx gives enterprises the freedom to create and manage fully tokenized strategies across any asset class, network, and financial system. From tokenized hedge funds, money market funds, and mutual funds to structured financial instruments, Onyx provides institutional-grade infrastructure covering the full lifecycle of a tokenized vehicle — including accounting, subscriptions, redemptions, NAV reporting, fee management, and investor onboarding — all delivered in a white-label environment that enterprises can deploy as their own.
Enzyme Myso is the premier protocol for creating, trading, and managing fully customizable on-chain options strategies. Myso enables issuers and trading firms to create and sell bespoke covered calls and cash-secured puts, settling on-chain either through its automated marketplace or over-the-counter. With deep cross-firm liquidity, non-custodial settlement, and a wide range of configurable parameters, from strike prices and expiries to auction mechanics and premium structures, Myso brings institutional-grade derivatives infrastructure entirely on-chain, eliminating counterparty risk and intermediary friction.
Until now, both protocols have operated exclusively within EVM-compatible environments. Going forward, they will be available as Canton-native applications as well, extending their reach to one of the most consequential institutional blockchain networks in the world.
From EVM to Multi-Chain: Why Canton, and Why NowThe decision to bring Enzyme Onyx and Myso to Canton is a deliberate strategic commitment — not simply a technical integration, but an alignment with the infrastructure we believe will define the normalization of blockchain in regulated financial markets.
Canton is designed as a network of networks, where each participating institution maintains its own sub-ledger while connecting with others via a shared synchronization layer enabling real-time settlement across multiple asset classes on a shared, interoperable infrastructure, without sacrificing privacy or control.
Unlike other approaches, Canton enforces visibility and authorization rules at the smart contract level, ensuring that parties can only see the portions of a transaction that apply to them. This architecture is built around the principle of data minimization — a requirement, not a preference, for regulated financial actors.
The institutions backing Canton speak to its trajectory: launched in 2023 by a consortium including BNP Paribas, Goldman Sachs, Deutsche Börse, CBOE, and Moody's, it was designed from the outset to modernize post-trade processes in global capital markets. Canton is not an experiment — it is becoming the reference network for institutional blockchain adoption.
For Enzyme, joining this ecosystem is a recognition that the normalization of on-chain financial markets will happen on infrastructure that institutional actors can trust and build upon with the confidence required by their regulatory obligations. Canton is that infrastructure.
Use Cases Unlocked on Canton : a step into modern financial marketBy porting Enzyme Onyx and Myso natively to Canton, we are enabling two critical financial use cases to operate within this institutional-grade ecosystem for the first time.
Tokenized Funds supporting on-chain and off-chain asset classes, Natively on CantonWith Enzyme Onyx on Canton, fund managers will be able to deploy and operate fully tokenized investment funds directly within the Canton network with the flexibility to run strategies spanning on-chain assets such as cryptocurrencies, and off-chain asset classes including equities, fixed income, T-Bills, real estate, and beyond. This means fund vehicles, including their subscription logic, valuation mechanisms, allocation policies, and redemption flows, will benefit from Canton's privacy-preserving architecture, where sensitive portfolio data is visible only to the appropriate counterparties, while settlement and synchronization occur in real time across participants.
For fund administrators, institutional investors, and asset managers engaging with Canton's ecosystem of regulated participants, this represents a meaningful step toward a fully native on-chain fund infrastructure that meets the standards of professional capital markets.
Options Strategies : Calls and Puts, American and European options Natively on CantonEnzyme Myso on Canton will bring structured derivatives to the network for the first time in a fully native and on-chain form. Institutions and sophisticated counterparties will be able to construct, issue, and settle Covered Calls and Cash-Secured Put options entirely within the Canton environment, with the privacy guarantees and atomic settlement finality that the network provides. This opens the door to on-chain derivatives infrastructure that does not compromise on confidentiality, counterparty controls, or regulatory compliance, making Myso a natural fit for the institutional actors and financial intermediaries who are building on Canton.
Our Commitment to EVM Remains UnwaveringExpanding to Canton does not represent a departure from our roots, it represents their natural extension. The EVM ecosystem remains Enzyme's historical home and a network in which we have deep, enduring confidence. The breadth of DeFi composability, the density of developer talent, and the maturity of EVM infrastructure continue to make it the most dynamic environment for decentralized finance. Enzyme Onyx and Myso will continue to evolve on EVM with the same level of dedication and ambition as always.
Enzyme joins Rayls as a launch partner, expanding tokenized fund infrastructure to global markets
Enzyme is pleased to announce that it is joining Rayls as a launch partner, bringing Enzyme Onyx and Enzyme Myso natively to the Rayls network. This marks a significant step in Enzyme's commitment to making institutional-grade tokenized fund infrastructure available wherever regulated financial markets are building on-chain.
Enzyme Onyx and Enzyme Myso: A Brief OverviewEnzyme Onyx is the complete technical stack for issuing, structuring, and administering tokenized funds and financial instruments. Built for the innovators of modern markets, Onyx gives enterprises the freedom to create and manage fully tokenized strategies across any asset class, network, and financial system. From tokenized hedge funds, money market funds, and mutual funds to structured financial instruments, Onyx provides institutional-grade infrastructure covering the full lifecycle of a tokenized vehicle (including accounting, subscriptions, redemptions, NAV reporting, fee management, and investor onboarding) all delivered in a white-label environment that enterprises can deploy as their own.
Enzyme Myso is the premier protocol for creating, trading, and managing fully customizable on-chain options strategies. Myso enables issuers and trading firms to create and sell bespoke covered calls and cash-secured puts, settling on-chain either through its automated marketplace or over-the-counter. With deep cross-firm liquidity, non-custodial settlement, and a wide range of configurable parameters, from strike prices and expiries to auction mechanics and premium structures, Myso brings institutional-grade derivatives infrastructure entirely on-chain, eliminating counterparty risk and intermediary friction.
Until now, both protocols have operated exclusively within the Ethereum ecosystem. Going forward, they will be available as Rayls-native platforms as well, extending their reach to one of the most consequential institutional blockchain networks in the world.
Expanding the Institutional Frontier: Why Rayls, and Why NowRayls is an EVM-compatible Layer 1 blockchain built specifically for financial institutions. Its architecture combines a compliant public chain with a network of private institutional nodes, enabling banks and regulated institutions to issue, settle, and manage financial assets on-chain while retaining the data privacy and compliance controls their operations require.
What distinguishes Rayls from most institutional blockchain networks is the depth of its real-world deployment. Rayls has been selected by the Central Bank of Brazil for the Drex wholesale CBDC pilot and is already installed within 16 of the largest banks in the region. Núclea, a leading financial market infrastructure provider, is utilizing Rayls to tokenize commercial receivables at scale, bringing high-volume financial assets onto a transparent, on-chain ledger. The network's global technical credibility is further evidenced by its performance in J.P. Morgan's Project EPIC benchmark. This evaluation of privacy-focused blockchain solutions for institutional finance ranked Rayls among the leading candidates.
By joining Rayls as a launch partner, Enzyme is ensuring that its global infrastructure for tokenized finance is integrated with an infrastructure built to handle the complexity and scale of modern, regulated capital markets.
What Enzyme Onyx and Myso Bring to RaylsBy deploying Enzyme Onyx and Enzyme Myso natively to Rayls, we are enabling two pivotal financial use cases to operate within this institutional-grade ecosystem for the first time.
Tokenized Funds supporting on-chain and off-chain asset classes, Natively on RaylsWith Enzyme Onyx on Rayls, fund managers will be able to deploy and operate fully tokenized investment funds directly within the Rayls blockchain with the flexibility to run strategies spanning on-chain assets such as cryptocurrencies, and off-chain asset classes including equities, fixed income, T-Bills, real estate, and beyond. This means fund vehicles, including their subscription logic, valuation mechanisms, allocation policies, and redemption flows, will benefit from Rayls' privacy-preserving and compliant architecture, where sensitive portfolio data is visible only to the appropriate counterparties, while settlement and synchronization occur in real time across participants.
For fund administrators, institutional investors, and asset managers engaging with the Rayls ecosystem, this represents a meaningful step toward a fully native on-chain infrastructure that meets the standards of professional capital markets.
Options Strategies : Calls and Puts Natively on RaylsEnzyme Myso on Rayls will bring structured derivatives to the network in a fully native and on-chain form. Institutions and sophisticated counterparties will be able to construct, issue, and settle Covered Calls and Cash-Secured Put options entirely within the Rayls environment, utilizing the privacy-preserving settlement and compliance controls that the network provides.
This opens the door to on-chain derivatives infrastructure that does not compromise on confidentiality, counterparty controls, or regulatory compliance, making Myso a natural fit for the institutional actors and financial intermediaries who are building on Rayls.
Our Commitment to Multi-Chain InfrastructureExpanding to Rayls reflects a principle for us: institutional tokenized finance will not settle on a single network. Different markets, different regulatory environments, and different institutional ecosystems will build on different infrastructure, and Enzyme's role is to be the operational layer that works across all of them.
PANews reported on April 14th that, according to an official announcement, based on recent reviews, Binance will add watch tags to more tokens and remove seed tags for corresponding tokens on April 14th, 2026. The tokens added to the watch tag list are: Harvest Finance (FARM), Highstreet (HIGH), Enzyme (MLN), Resolv (RESOLV), Syscoin (SYS), TrueFi (TRU), and Velodrome Finance (VELODROME). The token whose seed tag was removed is: Tether Gold (XAUT).
PANews reported on May 13 that, according to an official announcement, Binance has decided to suspend trading and delist the following cryptocurrencies at 11:00 AM (UTC+8) on May 27, 2026: Automata (ATA), Harvest Finance (FARM), Enzyme (MLN), Phoenix (PHB), and Syscoin (SYS).
Share to:
Author: PA一线
This content is for market information only and is not investment advice.
Follow PANews official accounts, navigate bull and bear markets together
Binance announced that it will delist the altcoins Automata (ATA), Harvest Finance (FARM), Enzyme (MLN), Phoenix (PHB), and Syscoin (SYS).
13.05.2026 - 08:10
Update: 13.05.2026 - 08:10
Binance, the world’s largest cryptocurrency exchange, started the day with an altcoin announcement. According to the announcement, six altcoins have been delisted.
Binance announced that it will delist the altcoins Automata (ATA), Harvest Finance (FARM), Enzyme (MLN), Phoenix (PHB), and Syscoin (SYS).
“Based on our latest assessments, we have decided to discontinue trading and delist the following tokens in all spot trading pairs on 27.05.2026 at 03:00 (UTC):”
ATA, FARM, MLN, PHB and SYS
Spot trading pairs for these altcoins will be discontinued.
All trading orders will be automatically deleted after the transactions in the relevant trading pairs have ended.
The token’s value will no longer be displayed in user accounts after delisting. Deposits of these tokens will not be credited to users’ accounts after 03:00 (UTC) on May 28, 2026.
Withdrawals of these tokens from Binance will no longer be supported after July 27, 2026, 03:00 (UTC).
Altcoin prices are falling following the news.
*This is not investment advice.
Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data!
Binance flagged seven tokens with its Monitoring Tag on April 14, triggering an immediate selloff across all affected assets.
The tokens include Harvest Finance (FARM), Highstreet (HIGH), Enzyme (MLN), Resolv (RESOLV), Syscoin (SYS), TrueFi (TRU), and Velodrome Finance (VELODROME). The designation signals elevated volatility and potential removal from the exchange.
7 Altcoins at Risk for Binance DelistingMarket reaction was swift following the announcement. SYS dropped 11.53% within minutes, leading the decline. MLN fell 6.89%, while VELODROME shed 6.09%.
HIGH lost 5.69%, RESOLV declined 4.99%, and TRU slipped 3.80%. FARM recorded the smallest drop at 2.00%.
Follow us on X to get the latest news as it happens
Altcoins Decline After Binance Adds Monitoring Tags. Source: TradingViewBinance’s Monitoring Tag has previously served as a warning signal for full removal. The exchange placed Beefy.Finance (BIFI) and Measurable Data Token (MDT) under the tag in June 2025.
FunToken (FUN) and Orchid (OXT) received it in March 2026. All four were confirmed for delisting on April 23, alongside FIO Protocol (FIO) and Wanchain (WAN).
That April 9 delisting notice triggered even sharper losses, with FUN crashing 27% and MDT dropping 22% within minutes.
“Tokens with the Monitoring Tag exhibit notably higher volatility and risks compared to other listed tokens. These tokens are closely monitored, with regular reviews conducted. Keep in mind that tokens with the Monitoring Tag are at risk of no longer meeting our listing criteria and being delisted from the platform,” Binance wrote.
Traders who wish to continue accessing the flagged tokens must now pass a quiz every 90 days on the Binance Spot or Margin platforms and accept the updated Terms of Use.
“The quizzes are set up to ensure users are aware of the risks before trading tokens with the Monitoring Tag or Seed Tag,” the exchange said.
In the same update, Binance also announced it will remove the Seed Tag from Tether Gold (XAUT). The Seed Tag designates newer, higher-risk listings and differs from the Monitoring Tag. Its removal signals that XAUT has met the exchange’s criteria.
Subscribe to our YouTube channel to watch leaders and journalists provide expert insights
